As the population in Japan ages, it is reported that, currently, one out of two Japanese will contract cancer. Patients and families continue to be pressed by the huge financial, physical, and emotional burden of cancer treatment. To improve this situation, researchers are working on "genomic medicine," by which genomic information is analyzed and used for treatment.